APO Research
Talk to an analyst

APO RESEARCH · REPORT

Faropenem Sodium

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Faropenem Sodium Market Outlook and Growth Opportunities 2026

22 December 2025195 pages

Choose your research edition.

Industry ResearchFaropenem Sodium Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Faropenem Sodium Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Faropenem Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Faropenem Sodium Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Faropenem Sodium Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Faropenem Sodium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Faropenem Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Faropenem Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Faropenem Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Faropenem Sodium market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Faropenem Sodium market include Lunan Pharmaceutical, Hunan Warrant Chiral Pharmaceutical, Zhejiang East Asia Pharmaceutical Co., Ltd, Unipex and Kopran (Parijat Enterprises), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Faropenem Sodium market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Faropenem Sodium and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Faropenem Sodium revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Faropenem Sodium market.

Faropenem Sodium Segment by Company

Lunan Pharmaceutical

Hunan Warrant Chiral Pharmaceutical

Zhejiang East Asia Pharmaceutical Co., Ltd

Unipex

Kopran (Parijat Enterprises)

Faropenem Sodium Segment by Type

Purity:≤99%

Purity:Above 99%

Faropenem Sodium Segment by Application

Injection Product

Table Product

Others

Faropenem Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Faropenem Sodium status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Faropenem Sodium key companies, revenue, market share, and recent developments.

3. To split the Faropenem Sodium breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Faropenem Sodium market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Faropenem Sodium significant trends, drivers, influence factors in global and regions.

6. To analyze Faropenem Sodium competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Faropenem Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Faropenem Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Faropenem Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Faropenem Sodium industry.

Chapter 3: Detailed analysis of Faropenem Sodium company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Faropenem Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Faropenem Sodium in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Faropenem Sodium Industry Trends Table 2. Faropenem Sodium Industry Drivers Table 3. Faropenem Sodium Industry Opportunities and Challenges Table 4. Faropenem Sodium Industry Restraints Table 5. Global Faropenem Sodium Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Faropenem Sodium Revenue Share by Company (2021-2026) Table 7. Global Faropenem Sodium Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Faropenem Sodium Key Company Manufacturing Base & Headquarters Table 9. Global Faropenem Sodium Company, Product Type & Application Table 10. Global Faropenem Sodium Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Faropenem Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Purity:≤99% Table 15. Significant Companies of Purity:Above 99% Table 16. Global Faropenem Sodium Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Faropenem Sodium Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Faropenem Sodium Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Faropenem Sodium Sales Value Share by Type (2021-2026) Table 20. Global Faropenem Sodium Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Injection Product Table 22. Significant Companies of Table Product Table 23. Significant Companies of Others Table 24. Global Faropenem Sodium Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Faropenem Sodium Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Faropenem Sodium Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Faropenem Sodium Sales Value Share by Application (2021-2026) Table 28. Global Faropenem Sodium Sales Value Share by Application (2027-2032) Table 29. Global Faropenem Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Faropenem Sodium Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Faropenem Sodium Sales Value Share by Region (2021-2026) Table 32. Global Faropenem Sodium Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Faropenem Sodium Sales Value Share by Region (2027-2032) Table 34. Global Faropenem Sodium Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Faropenem Sodium Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Faropenem Sodium Sales Value Market Share by Country (2021-2026) Table 37. Global Faropenem Sodium Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Faropenem Sodium Sales Value Market Share by Country (2027-2032) Table 39. Lunan Pharmaceutical Company Information Table 40. Lunan Pharmaceutical Business Overview Table 41. Lunan Pharmaceutical Faropenem Sodium Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Lunan Pharmaceutical Faropenem Sodium Product Portfolio Table 43. Lunan Pharmaceutical Recent Development Table 44. Hunan Warrant Chiral Pharmaceutical Company Information Table 45. Hunan Warrant Chiral Pharmaceutical Business Overview Table 46. Hunan Warrant Chiral Pharmaceutical Faropenem Sodium Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Hunan Warrant Chiral Pharmaceutical Faropenem Sodium Product Portfolio Table 48. Hunan Warrant Chiral Pharmaceutical Recent Development Table 49. Zhejiang East Asia Pharmaceutical Co., Ltd Company Information Table 50. Zhejiang East Asia Pharmaceutical Co., Ltd Business Overview Table 51. Zhejiang East Asia Pharmaceutical Co., Ltd Faropenem Sodium Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Zhejiang East Asia Pharmaceutical Co., Ltd Faropenem Sodium Product Portfolio Table 53. Zhejiang East Asia Pharmaceutical Co., Ltd Recent Development Table 54. Unipex Company Information Table 55. Unipex Business Overview Table 56. Unipex Faropenem Sodium Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Unipex Faropenem Sodium Product Portfolio Table 58. Unipex Recent Development Table 59. Kopran (Parijat Enterprises) Company Information Table 60. Kopran (Parijat Enterprises) Business Overview Table 61. Kopran (Parijat Enterprises) Faropenem Sodium Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Kopran (Parijat Enterprises) Faropenem Sodium Product Portfolio Table 63. Kopran (Parijat Enterprises) Recent Development Table 64. Research Programs/Design for This Report Table 65. Authors List of This Report Table 66. Secondary Sources Table 67. Primary Sources List of Figures Figure 1. Faropenem Sodium Product Image Figure 2. Global Faropenem Sodium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Faropenem Sodium Market Size (2021-2032) & (US$ Million) Figure 4. Global Faropenem Sodium Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Purity:≤99% Image Figure 8. Purity:Above 99% Image Figure 9. Global Faropenem Sodium Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Faropenem Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Faropenem Sodium Sales Value Share by Type (2021-2032) Figure 12. Injection Product Image Figure 13. Table Product Image Figure 14. Others Image Figure 15. Global Faropenem Sodium Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Faropenem Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Faropenem Sodium Sales Value Share by Application (2021-2032) Figure 18. Global Faropenem Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Faropenem Sodium Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Faropenem Sodium Sales Value (2021-2032) & (US$ Million) Figure 21. North America Faropenem Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Faropenem Sodium Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Faropenem Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Faropenem Sodium Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Faropenem Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Faropenem Sodium Sales Value (2021-2032) & (US$ Million) Figure 27. South America Faropenem Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Faropenem Sodium Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Faropenem Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Faropenem Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Faropenem Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Faropenem Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Purity:≤99%
  • Purity:Above 99%
Applications
  • Injection Product
  • Table Product
  • Others
Companies covered
  • Lunan Pharmaceutical
  • Hunan Warrant Chiral Pharmaceutical
  • Zhejiang East Asia Pharmaceutical Co., Ltd
  • Unipex
  • Kopran (Parijat Enterprises)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Faropenem Sodium Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Faropenem Sodium Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Faropenem Sodium Market Dynamics
  1. 2.1 Faropenem Sodium Industry Trends
  2. 2.2 Faropenem Sodium Industry Drivers
  3. 2.3 Faropenem Sodium Industry Opportunities and Challenges
  4. 2.4 Faropenem Sodium Industry Restraints
3 Faropenem Sodium Market by Company
  1. 3.1 Global Faropenem Sodium Company Revenue Ranking in 2025
  2. 3.2 Global Faropenem Sodium Revenue by Company (2021-2026)
  3. 3.3 Global Faropenem Sodium Company Ranking (2024-2026)
  4. 3.4 Global Faropenem Sodium Company Manufacturing Base and Headquarters
  5. 3.5 Global Faropenem Sodium Company Product Type and Application
  6. 3.6 Global Faropenem Sodium Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Faropenem Sodium Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Faropenem Sodium Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Faropenem Sodium Market by Type
  1. 4.1 Faropenem Sodium Type Introduction
  2. 4.1.1 Purity:≤99%
  3. 4.1.2 Purity:Above 99%
  4. 4.2 Global Faropenem Sodium Sales Value by Type
  5. 4.2.1 Global Faropenem Sodium Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Faropenem Sodium Sales Value by Type (2021-2032)
  7. 4.2.3 Global Faropenem Sodium Sales Value Share by Type (2021-2032)
5 Faropenem Sodium Market by Application
  1. 5.1 Faropenem Sodium Application Introduction
  2. 5.1.1 Injection Product
  3. 5.1.2 Table Product
  4. 5.1.3 Others
  5. 5.2 Global Faropenem Sodium Sales Value by Application
  6. 5.2.1 Global Faropenem Sodium Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Faropenem Sodium Sales Value by Application (2021-2032)
  8. 5.2.3 Global Faropenem Sodium Sales Value Share by Application (2021-2032)
6 Faropenem Sodium Regional Value Analysis
  1. 6.1 Global Faropenem Sodium Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Faropenem Sodium Sales Value by Region (2021-2032)
  3. 6.2.1 Global Faropenem Sodium Sales Value by Region: 2021-2026
  4. 6.2.2 Global Faropenem Sodium Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Faropenem Sodium Sales Value (2021-2032)
  7. 6.3.2 North America Faropenem Sodium Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Faropenem Sodium Sales Value (2021-2032)
  10. 6.4.2 Europe Faropenem Sodium Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Faropenem Sodium Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Faropenem Sodium Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Faropenem Sodium Sales Value (2021-2032)
  16. 6.6.2 South America Faropenem Sodium Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Faropenem Sodium Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Faropenem Sodium Sales Value Share by Country, 2025 VS 2032
7 Faropenem Sodium Country-level Value Analysis
  1. 7.1 Global Faropenem Sodium Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Faropenem Sodium Sales Value by Country (2021-2032)
  3. 7.2.1 Global Faropenem Sodium Sales Value by Country (2021-2026)
  4. 7.2.2 Global Faropenem Sodium Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Faropenem Sodium Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Faropenem Sodium Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Faropenem Sodium Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Faropenem Sodium Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Faropenem Sodium Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Faropenem Sodium Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Faropenem Sodium Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Faropenem Sodium Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Faropenem Sodium Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Faropenem Sodium Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Faropenem Sodium Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Faropenem Sodium Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Faropenem Sodium Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Faropenem Sodium Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Faropenem Sodium Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Faropenem Sodium Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Faropenem Sodium Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Faropenem Sodium Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Faropenem Sodium Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Faropenem Sodium Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Faropenem Sodium Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Faropenem Sodium Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Faropenem Sodium Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Faropenem Sodium Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Faropenem Sodium Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Faropenem Sodium Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Faropenem Sodium Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Faropenem Sodium Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Faropenem Sodium Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Faropenem Sodium Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lunan Pharmaceutical
  2. 8.1.1 Lunan Pharmaceutical Company Information
  3. 8.1.2 Lunan Pharmaceutical Business Overview
  4. 8.1.3 Lunan Pharmaceutical Faropenem Sodium Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lunan Pharmaceutical Faropenem Sodium Product Portfolio
  6. 8.1.5 Lunan Pharmaceutical Recent Developments
  7. 8.2 Hunan Warrant Chiral Pharmaceutical
  8. 8.2.1 Hunan Warrant Chiral Pharmaceutical Company Information
  9. 8.2.2 Hunan Warrant Chiral Pharmaceutical Business Overview
  10. 8.2.3 Hunan Warrant Chiral Pharmaceutical Faropenem Sodium Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hunan Warrant Chiral Pharmaceutical Faropenem Sodium Product Portfolio
  12. 8.2.5 Hunan Warrant Chiral Pharmaceutical Recent Developments
  13. 8.3 Zhejiang East Asia Pharmaceutical Co., Ltd
  14. 8.3.1 Zhejiang East Asia Pharmaceutical Co., Ltd Company Information
  15. 8.3.2 Zhejiang East Asia Pharmaceutical Co., Ltd Business Overview
  16. 8.3.3 Zhejiang East Asia Pharmaceutical Co., Ltd Faropenem Sodium Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zhejiang East Asia Pharmaceutical Co., Ltd Faropenem Sodium Product Portfolio
  18. 8.3.5 Zhejiang East Asia Pharmaceutical Co., Ltd Recent Developments
  19. 8.4 Unipex
  20. 8.4.1 Unipex Company Information
  21. 8.4.2 Unipex Business Overview
  22. 8.4.3 Unipex Faropenem Sodium Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Unipex Faropenem Sodium Product Portfolio
  24. 8.4.5 Unipex Recent Developments
  25. 8.5 Kopran (Parijat Enterprises)
  26. 8.5.1 Kopran (Parijat Enterprises) Company Information
  27. 8.5.2 Kopran (Parijat Enterprises) Business Overview
  28. 8.5.3 Kopran (Parijat Enterprises) Faropenem Sodium Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kopran (Parijat Enterprises) Faropenem Sodium Product Portfolio
  30. 8.5.5 Kopran (Parijat Enterprises) Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst